Respiratory Management of Patients with Neuromuscular Weakness

Publication Date: March 13, 2023

Last Updated: March 14, 2023

Summary of Recommendations

Use and Timing of Pulmonary Function Testing

For patients with neuromuscular disease (NMD) at risk for respiratory complications, we recommend pulmonary function testing (PFT) to assist with management decisions. (GPS, )

Remarks: PFT is a low-cost intervention. The panel recommends that spirometry with forced 79 or slow vital capacity (FVC or SVC) and maximum inspiratory and expiratory pressure (MIP/MEP) or SNIP and PCF be considered in patients with NMD when available according to regional practice patterns.

Respiratory Management of Patients with Neuromuscular Weakness

Summary of Recommendations

Use and Timing of Pulmonary Function Testing

Overview

Title

Authoring Organization